Alnylam Pharmaceuticals, Inc. (ALNY)
397.66
+0.41
(+0.10%)
USD |
NASDAQ |
Dec 31, 16:00
397.66
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 52.54B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.83B |
| Insmed, Inc. | 37.13B |
| Pfizer Inc. | 141.60B |
| Glaukos Corp. | 6.484B |
| BridgeBio Pharma, Inc. | 14.74B |
Market Cap Related Metrics
| PE Ratio | 1653.47 |
| PS Ratio | 16.31 |
| Price to Book Value | 224.62 |
| Price to Free Cash Flow | 236.57 |
| Price | 397.66 |
| Earnings Yield | 0.06% |
| Operating PE Ratio | 197.84 |
| Normalized PE Ratio | 256.54 |